While rhabdoid tumors associated with RTPS1 exhibit an overall survival of 10–20% [7, 44], a total of six out of seven patients with ATRT and RTPS2 died within 20 months in the series by Hasselblatt et al. [9] (Fig. 2b). This evidence concerns the gene SMARCA4 and rhabdoid tumor.